Nov. 2021: ACAAI Annual Scientific Meeting
STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for the Potential Treatment of HAE
Oct. 2021: NORD Summit
Burdens of Disease and Treatment in Hereditary Angioedema: Interview Insights from HAE Patients
Our Commitment
Patient Stories
Resources
Overview
Navenibart (STAR-0215)
STAR-0310
Expanded Access Policy
Mission & Values
Our Team
Join Us
Partner with Us
Inclusion & Belonging
Corporate Responsibility
Contact Us
News Alerts
✕
